NCT05420831

Brief Summary

This is a prospective randomized controlled study, designed to compare efficacy and safety of two methods of apical fixation in patients with pelvic organ prolapse (POP) - sacrospinous hysteropexy (SSHP) with synthetic mesh and laparoscopic sacrohysteropexy (LSHP), and the impact of the surgery on quality of life.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 18, 2022

Completed
28 days until next milestone

First Posted

Study publicly available on registry

June 15, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

September 9, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 2, 2023

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 9, 2025

Completed
Last Updated

December 27, 2023

Status Verified

December 1, 2023

Enrollment Period

11 months

First QC Date

May 18, 2022

Last Update Submit

December 24, 2023

Conditions

Keywords

sacrohysteropexypelvic organ prolapseapical prolapsevaginal repairvaginal meshsacrospinous fixation

Outcome Measures

Primary Outcomes (1)

  • Objective cure rate

    The patient is considered cured if there is no prolapse beyond the hymen and the cervix is above -1 cm according to POP-Q (0-1 stage)

    24 months (2 years)

Secondary Outcomes (4)

  • Satisfaction with the surgery

    Measured postoperatively at intervals of 6, 12 and 24 months postoperatively

  • The impact of treatment on sexual function

    Measured postoperatively at intervals of 6, 12 and 24 months postoperatively

  • The impact of treatment on the quality of life

    Measured postoperatively at intervals of 6, 12 and 24 months postoperatively

  • Observed complications

    Measured postoperatively at intervals of 6, 12 and 24 months postoperatively

Study Arms (2)

Sacrospinous fixation of the vaginal apex with the synthetic mesh

ACTIVE COMPARATOR
Procedure: Vaginal

Laparoscopic sacrocolpopexy

ACTIVE COMPARATOR
Procedure: Laparoscopic

Interventions

VaginalPROCEDURE

Sacrospinous hysteropexy using the synthetic mesh

Sacrospinous fixation of the vaginal apex with the synthetic mesh
LaparoscopicPROCEDURE

Laparoscopic Sacrohysteropexy

Laparoscopic sacrocolpopexy

Eligibility Criteria

Age45 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The subject is a woman with anterior and apical compartment pelvic organ prolapse
  • The age of a subject is 45-80 years
  • Leading point of prolapse is at the level of the hymen or distal to the hymen (Ba, C\>=0 according to POP-Q classification)
  • The subject gave written consent to participate in the study
  • The subject is able to evaluate the risks of the treatment and make an independent decision on participation in the study
  • The subject is able to fill up validated questionnaires and come to the control visit after the surgery

You may not qualify if:

  • The subject has an active urinary tract infection or skin infection in the region of surgery or acute infectious disease
  • The subject had prior surgery for POP, stress urinary incontinence (SUI) or hysterectomy
  • The subject has history of pelvic cancer
  • The subject has chronic pelvic pain
  • The subject has cervical elongation
  • The subject has severe obesity (BMI \> 30)
  • The subject has postoperative scars/suspected adhesions in the ares of surgical access to the abdomen
  • The subject has gynecological diseases (recurrent uterine bleeding, endometrial hyperplasia, the presence of atypical cells in cervical smears, adenomyosis, multiple uterine myoma)
  • The subject has urinary incontinence
  • The subject is planning pregnancy
  • The subject is unable to visit postoperative check-ups
  • Refusal from participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saint-Petersburg State University Hospital

Saint Petersburg, 190103, Russia

Location

MeSH Terms

Conditions

Pelvic Organ Prolapse

Interventions

Laparoscopy

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

EndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Dmitry Shkarupa, MD, PhD

    Saint Petersburg State University, Russia

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ph.D., Deputy Director for medical care, Chief Urologist of Saint Petersburg State University Clinic of advanced medical technologies n.a. N.I.Pirogov.

Study Record Dates

First Submitted

May 18, 2022

First Posted

June 15, 2022

Study Start

September 9, 2022

Primary Completion

August 2, 2023

Study Completion

May 9, 2025

Last Updated

December 27, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations